Tech Journal of Mauritius
SEE OTHER BRANDS

Exploring the science and technology news of Mauritius

Tech Journal of Mauritius: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Mauritius.

Press releases published on July 25, 2025

Sagtec Global (NASDAQ SAGT) Achieves Key Milestone in UAE Smart Hospitality Deal; On Track for 2025 Revenue Recognition
VERSES® Featured in IEEE Spectrum
Liminatus Pharma Inc. Evaluates Formation of Digital Asset Investment Vehicle Targeting Up To $500 Million in Capital Strategies
Intelligent Bio Solutions Inc. Enters Into Agreements to Raise $3.8 Million in Gross Proceeds
UPCX Wallet Releases New Features and Opens Testnet for Public Testing
Orangekloud Announces Launch of eMOBIQ® AI Platform
Madrigal Pharmaceuticals to Release Second-Quarter 2025 Financial Results and Host Webcast on August 5, 2025
Beyond Air Schedules First Fiscal Quarter 2026 Financial Results Conference Call and Webcast
Cronos Group Inc. to Hold 2025 Second Quarter Earnings Conference Call on August 7, 2025
CareCloud Announces Preferred Stock Dividend Payments
Lyell Immunopharma Announces up to $100 Million Equity Private Placement
GivBux Urges Shareholders to Submit Statements as Share Reconciliation Continues
BriaCell Announces Two Clinical Data Poster Presentations at ESMO 2025
ZURZUVAE® (zuranolone) Receives Positive Opinion from CHMP for the Treatment of Women with Postpartum Depression
Sobi Announces U.S. Food and Drug Administration Approves Doptelet® (avatrombopag) for the Treatment of Thrombocytopenia in Pediatric Patients One Year and Older with Persistent or Chronic Immune Thrombocytopenia (ITP)
Ambow Launches HybriU Global Learning Network, Connecting U.S. Universities with Students Worldwide
Aurora Mobile Leverages Quantum Computing to Accelerate Business Model Innovation
Nürburgring chooses vivenu: New partnership accelerates ticketing innovation
Where Dawn Breaks and Dreams Take Root: The GEBE Family
Pfizer und BioNTech erhalten positive CHMP-Empfehlung für an LP.8.1 angepassten COVID-19-Impfstoff in der Europäischen Union

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions